Hanson McClain Advisors »

Edgewise Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $820 45 18.24
2023-12-31 $493 45 10.96
2023-06-30 $1.7k 221 7.75

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)

View all positions for Hanson McClain Advisors

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
FMR
Baker Bros. Advisors
BlackRock
Vanguard Group
Viking Global Investors
Frazier Life Sciences Management
Cormorant Asset Management
Deerfield Management Company
Citadel Advisors
Paradigm Biocapital Advisors
Perceptive Advisors
VR Adviser
Henderson Group

View all funds holding Edgewise Therapeutics